TP53-specific mutations serve as a potential biomarker for homologous recombination deficiency in breast cancer: a clinical next-generation sequencing study

• DOI: 10.1093/pcmedi/pbae009
• Publication Date: 2024-04-08T17:29:24Z
• Authors: Yongsheng Huang; Shuwei Ren; Linxiaoxiao Ding; Yuanling Jiang; Jiahuan Luo; Jinghua Huang; Xinke Yin; Jianli Zhao; Sha Fu; Jianwei Liao
• Keywords: BRCA2 Protein

mutations and homologous recombination deficiency (HRD) occur frequently in breast cancer. However, the characteristics of